"Scleroderma, Systemic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.
| Descriptor ID |
D012595
|
| MeSH Number(s) |
C17.300.799 C17.800.784
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Scleroderma, Systemic".
Below are MeSH descriptors whose meaning is more specific than "Scleroderma, Systemic".
This graph shows the total number of publications written about "Scleroderma, Systemic" by people in this website by year, and whether "Scleroderma, Systemic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 4 | 0 | 4 |
| 2012 | 1 | 1 | 2 |
| 2013 | 3 | 0 | 3 |
| 2014 | 3 | 0 | 3 |
| 2015 | 4 | 0 | 4 |
| 2016 | 2 | 0 | 2 |
| 2017 | 83 | 4 | 87 |
| 2018 | 56 | 4 | 60 |
| 2019 | 25 | 2 | 27 |
| 2020 | 14 | 3 | 17 |
| 2021 | 5 | 0 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Scleroderma, Systemic" by people in Profiles.
-
Similarities between COVID-19 and systemic sclerosis early vasculopathy: A "viral" challenge for future research in scleroderma. Autoimmun Rev. 2021 Oct; 20(10):102899.
-
COVID-19 vaccine hesitancy in systemic sclerosis. Clin Exp Rheumatol. 2021 Jul-Aug; 39 Suppl 131(4):165-166.
-
Case Report: Systemic Sclerosis After Covid-19 Infection. Front Immunol. 2021; 12:686699.
-
SARS-COV-2 vaccination after stem cell transplantation for scleroderma. Ann Rheum Dis. 2021 10; 80(10):1354-1355.
-
Systemic sclerosis and COVID-19: what's new in the literature. Clin Exp Rheumatol. 2021 Jul-Aug; 39 Suppl 131(4):157-158.
-
Severe skin ulcer in systemic scleroderma due to severe acute respiratory syndrome coronavirus 2 infection. J Dermatol. 2021 Jul; 48(7):e343-e344.
-
The clinical course of COVID-19 in systemic sclerosis patients, report from 150 patients. Intern Emerg Med. 2021 10; 16(7):2001-2003.
-
Resilience of systemic sclerosis patients following the first COVID-19 wave in Italy. Scand J Rheumatol. 2021 09; 50(5):411-412.
-
Patient Perspectives on the Effect of the SARS-CoV-2 Pandemic on Patients With Systemic Sclerosis: An International Patient Survey. J Clin Rheumatol. 2021 Jan 01; 27(1):31-33.
-
Autoimmune connective tissue diseases in the COVID-19 pandemic. Clin Dermatol. 2021 Jan-Feb; 39(1):56-63.